Myocarditis cardiac transplantation: Difference between revisions
Jump to navigation
Jump to search
(New page: {{Myocarditis}} {{CMG}} ==Overview== Cardiac transplantation is sometimes required to treat refractory giant cell myocarditis. However, the condition can recur in post-transplant...) |
No edit summary |
||
| Line 8: | Line 8: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Cardiology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date cardiology]] | |||
[[Category:Overview complete]] | |||
Revision as of 23:11, 11 September 2011
|
Myocarditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myocarditis cardiac transplantation On the Web |
|
American Roentgen Ray Society Images of Myocarditis cardiac transplantation |
|
Risk calculators and risk factors for Myocarditis cardiac transplantation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cardiac transplantation is sometimes required to treat refractory giant cell myocarditis. However, the condition can recur in post-transplant patients. Recurrence of biopsy proven giant cell myocarditis between 3 weeks to 9 years was observed in 9 of 34 cardiac transplant patients [1].
References
- ↑ Cooper LT, Berry GJ, Shabetai R (1997). "Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators". N Engl J Med. 336 (26): 1860–6. doi:10.1056/NEJM199706263362603. PMID 9197214.